Biomarker Technologies(BMK), as one of the leading providers of genomics services, is founded in 2009, headquartered in Beijing, China. BMK has been actively engaged in the innovation and development of high-throughput sequencing technologies and bioinformatics for over 12 years. Its business consists of science and technology services, medical technology services and BioCloud bioinformatics platform. BMK has established long-term cooperation with various organizations, including universities, hospitals, research institutes, independent laboratories, pharmaceutical companies, plant breeding companies, medical and health institutes, etc., sitting in over 50 regions all over the world.
Company Details
- Employees
- 4
- Address
- Rm 06, 13a/f South Tower World Finance Ctr Harbour City 17 Canton Rd, Tst, Kln, Hong Kong, 香港,china
- Industry
- Biotechnology
- Website
- https://www.bmkgene.com/
- HQ
- 香港
Bmkgene Amea Questions
Bmkgene Amea's website is https://www.bmkgene.com/
Bmkgene Amea's LinkedIn profile is https://cn.linkedin.com/company/biomarker-bmkgene-amea
Bmkgene Amea has
4 employees.
View email and phone details for 4
employees at Bmkgene Amea.
Bmkgene Amea's industry is
Biotechnology
Bmkgene Amea's top competitors are
Nanotech Innovation Limited,
Nimgenetics,
Embl Australia,
Bmkgene Europe,
百迈客生物,
Thermo Fisher Scientific,
Bmkgene America,
Pacbio,
Johnson & Johnson,
Novogene Europe.
Bmkgene Amea's categories are Biotechnology
